Market Size of South America Ovarian Cancer Diagnostics and Therapeutics Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 9.20 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
South America Ovarian Cancer Diagnostics & Therapeutics Market Analysis
The rising incidences of ovarian cancer are one of the primary drivers for the market. The cancer burden is increasing, owing to factors such as the aging population, poor diet, smoking, and physical inactivity. According to Globocan, in 2018, there were around 243,588 deaths due to cancer in Brazil. Ovarian cancer (OC) is the most common cancer among women. OC has a high mortality rate and is difficult to diagnose. Due to its silent progression, it is contributing to the high mortality rate. Thus, due to the increasing incidence of ovarian cancer, the market for cancer diagnostics and therapeutics is expected to see stable growth in South America. Additionally, the rising geriatric population and increase in healthcare expenditure also contribute to the growth of the market.
